• Publications
  • Influence
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
CONTEXT Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve risk stratification of this cancer. OBJECTIVE The objective of the study was to investigate theExpand
  • 832
  • 42
American Thyroid Association guidelines for detection of thyroid dysfunction.
OBJECTIVE To define the optimal approach to identify patients with thyroid dysfunction. PARTICIPANTS The 8-member Standards of Care Committee of the American Thyroid Association prepared a draft,Expand
  • 520
  • 23
  • PDF
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.
CONTEXT After surgery for differentiated thyroid carcinoma, many patients are treated with radioiodine to ablate remnant thyroid tissue. This procedure has been performed with the patient in theExpand
  • 398
  • 21
  • PDF
Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.
CONTEXT There has not been a comprehensive compilation of data regarding the epidemiology of all endocrine and metabolic disorders in the United States. EVIDENCE ACQUISITION We included 54Expand
  • 390
  • 20
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Recent studies have provided new information regarding the optimal surveillance protocols for low-risk patients with differentiated thyroid cancer (DTC). This article summarizes the main issuesExpand
  • 605
  • 18
BRAF mutation in papillary thyroid carcinoma.
The BRAF gene has been found to be activated by mutation in human cancers, predominantly in malignant melanoma. We tested 476 primary tumors, including 214 lung, 126 head and neck, 54 thyroid, 27Expand
  • 681
  • 17
  • PDF
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
A set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with thyroid nodules or thyroid cancer was developed by consensus by an 11-memberExpand
  • 444
  • 17
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
UNLABELLED Technical aspects and results of the dosimetric assessments of postoperative radioiodine ablation in the framework of an international, prospective, controlled, randomized, comparativeExpand
  • 286
  • 16
  • PDF
Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in
Few modifiable exposures influencing autoimmune thyroid disease have been identified. Studies evaluating cigarette smoke and thyroid disorders have yielded conflicting results. The relationshipExpand
  • 180
  • 16
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
Recombinant human TSH has been developed to facilitate monitoring for thyroid carcinoma recurrence or persistence without the attendant morbidity of hypothyroidism seen after thyroid hormoneExpand
  • 550
  • 15